Objective: Inconsistent definitions of atrial fibrillation after coronary artery bypass grafting have caused uncertainty about its incidence and risk. We examined the extent to which limiting the definition to post-coronary artery bypass grafting atrial fibrillation events requiring treatment underestimates its incidence and impact on 30-day mortality.
Perspective
The association between post-CABG AF and poor survival is well known, but the definition has not been standardized to ensure all patients at risk are identified. The STS data (AF/flutter requiring treatment) miss approximately 9600 US patients with new-onset AF after isolated CABG annually; our results show they carry an unrecognized significantly increased risk for 30-day mortality.
See Editorial Commentary page 1267. The Heart Hospital Baylor Plano, Plano, Tex; c Development of atrial fibrillation (AF) after cardiac surgery was considered a minor, self-limiting complication until relatively recently. [1] [2] [3] [4] [5] Approximately a decade ago, however, evidence started emerging that it was independently associated with poorer survival after coronary artery bypass grafting (CABG). 2, 3, [6] [7] [8] [9] It is now recognized as a serious complication, and practice guidelines and quality measures have been introduced related to its prevention. [10] [11] [12] [13] However, no standard definition has been established to ensure all patients who carry this risk for poor outcomes are identified for follow-up and management after discharge. Research studies to date have used a wide variety of definitions and means of detecting AF, 14, 15 creating uncertainty about its true incidence and how effectively the risks it is associated with are being managed.
The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database incorporates data from approximately 95% of the cardiac surgery programs in the United States, 16 making it and the regional STS-certified databases built around the same routinely collected data valuable resources for studies investigating postoperative AF, [17] [18] [19] and therefore influential in determining the definition of postoperative AF on which the evidence base regarding its prevention and management will be built. Currently, the STS defines postoperative AF as ''atrial fibrillation/ flutter requiring treatment.'' 20 Because there are no criteria for the determination of when treatment is required, this is an ambiguous definition, subject to the vagaries of differing indications for treatment between physicians and hospitals, and may substantially underestimate the incidence of postoperative AF, and, thus, the patients at risk for late mortality. Given the clinical significance, the question arises as to whether the STS definition needs to be updated and refined.
To address this question, we used data from a large, multicenter observational study to compare the riskadjusted incidence of new-onset post-CABG AF defined according to the STS data and definition versus any episode detected via continuous in-hospital electrocardiogram (ECG)/telemetry monitoring and documented by a physician in the patient's chart, regardless of duration or need for treatment, but not captured in the STS data. We then compared 30-day mortality between these 2 groups and patients who did not develop AF to determine whether the difference in definition is clinically meaningful.
MATERIALS AND METHODS Patients and Setting
This multicenter observational study was conducted in 9268 consecutive patients without a history of AF who underwent isolated CABG between January 1, 2004, and December 31, 2010, at Baylor University Medical Center (Dallas, Tex), The Heart Hospital Baylor Plano (Plano, Tex), Emory University (Atlanta, Ga), University of Virginia (Charlottesville, Va), or Washington University (St Louis, Mo). Patients were excluded if they had preoperative endocarditis or a ventricular assist device. The study was approved by the institutional review boards of all participating centers.
Data Collection and Outcome Measures
Data regarding patient and operative characteristics routinely collected for the STS database were augmented with detailed data regarding AF events abstracted from medical records, based on ECG findings.
The outcome measures were the adjusted incidence of new-onset post-CABG AF defined as (1) AF/flutter requiring treatment (AF identified in the STS data) 20 and (2) any episode detected via continuous in-hospital ECG/telemetry monitoring and documented by a physician in the patient's chart, regardless of duration or need for treatment, but not recorded in the STS data (AF not identified in the STS data). Mortality at 30 days postsurgery was assessed using the vital status information contained within the STS data and compared between the patients with these 2 definitions of post-CABG AF and the patients without post-CABG AF.
Statistical Analysis
The overall adjusted incidence of new-onset post-CABG AF (including all patients with any episode detected via continuous in-hospital ECG/ telemetry monitoring and documented by a physician in the patient's chart, regardless of whether it was also captured in the STS data) was assessed with a generalized estimating equation (GEE) model approach to account for patient and site variability. The GEE model was adjusted for the STS risk of mortality 21 and time of operation (incremental month starting from January 2004 [month 1] to December 2010 [month 84]). All continuous covariates were modeled with a 5-knot restricted cubic spline. 22, 23 The same model, with the addition of the interaction between AF definition and time of operation, was used to compare the adjusted incidence of new-onset post-CABG AF according to whether or not the patient's AF was identified in the STS data. Model estimates were used to compute the adjusted new-onset post-CABG AF incidences, odds ratios (ORs), 95% confidence intervals (CIs), and P values.
The impact of limiting the definition of post-CABG AF to events requiring treatment on the detection of new-onset AF in the US population undergoing isolated CABG was estimated by applying the risk-adjusted difference in incidence between patients whose AF events were versus were not identified in the STS data in our study population to the total number of isolated CABG procedures performed in the United States
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Scanning this QR code will take you to the article title page. To determine the effect of the definition of post-CABG AF used (identified in the STS data vs not) on 30-day mortality, we used a GEE logistic model with 30-day mortality as the outcome variable and post-CABG AF (no AF, AF according to STS data, and AF not identified in the STS data) as the main predictor, with model covariates including the STS risk of mortality 21 and time of operation, modeled using the approach and spline functions 22, 23 described earlier. Model estimates were used to compute ORs, 95% CIs, and P values. All analyses were performed using SAS 9.3 (SAS Institute, Inc, Cary, NC). Table 1 shows the clinical and demographic characteristics of the study population by new-onset post-CABG AF status, with patients who had any episode of post-CABG AF detected via continuous in-hospital ECG/telemetry monitoring and documented by a physician in the patient's chart divided into those also identified as having AF in the STS data versus those missed in the STS data. Table 2 shows the unadjusted and adjusted incidence of post-CABG AF under each of these definitions by year, as well as unadjusted 30-day mortality by year. Overall, post-CABG AF incidence (adjusted for STS risk of mortality, time of operation, and interaction between AF and time of operation) was 33.4%, including 27.0% identified in the STS data and 6.4% missed by the STS data. Significant differences in adjusted incidence of post-CABG AF were observed over time (Table 2 and Figure 1) , and the STS data/definition systematically and significantly underestimated post-CABG AF (Figure 1) .
RESULTS
In 2013, 147,600 isolated CABG surgeries were reported nationwide in the STS Adult Cardiac Surgery Database. 24 The significant underestimation observed using the STS data and definition translates into 9600 (95% CI, 9420-9780) undetected/missed cases of AF after isolated CABG in the United States each year.
The unadjusted 30-day mortality rate was 1.5% overall (143 deaths). Breaking it down by post-CABG AF status, the rate was 0.8% in the patients with no AF, 2.8% in the patients with AF identified in the STS data, and 6.4% in the patients with AF not identified in the STS data. Among patients with post-CABG AF, those not identified in the STS data had significantly higher risk-adjusted 30-day mortality (OR, 2.08; 95% CI, 1.17-3.69) (Figure 2 ).
DISCUSSION

Principal Findings
Our results show that limiting the definition of post-CABG AF to episodes requiring treatment significantly underestimates the incidence of this serious complication of CABG. Although the unadjusted and risk-adjusted incidences of new-onset post-CABG AF we observed under both definitions were consistent with the range of 10% to 40% frequently cited for CABG, 15, 25, 26 the results from the more inclusive definition (33.4% after risk adjustment) indicate that true incidence is toward the high end of this range. Overall, the STS definition missed a risk-adjusted 6.4% of patients undergoing isolated CABG who developed new-onset post-CABG AF (an estimated 9600 US isolated CABG cases each year), a group our results show have a risk for 30-day mortality that is significantly greater than the patients whose post-CABG AF is captured by the STS data and definition.
Comparison With the Literature
The patterns of comorbidities, age, body habitus, ejection fraction, and use of elective CABG in our study cohort are similar to those reported for isolated CABG cases from 2000 to 2009 in the national STS Adult Cardiac Surgery database, 27 indicating that our results are likely generalizable to the broader population of US patients undergoing CABG. We also saw similar patterns in the unadjusted operative mortality rate. 27 With respect to trends over time in incidence of new-onset post-CABG AF, our results differ from the national findings that show a statistically significant increase in both the unadjusted incidence (from 19.8% in 2000 to 21.1% in 2009, P <.0001) and the risk-adjusted incidence (from 20.0% in 2000 to 20.5% in 2009, P ¼ .04). 27 The national cohort also reported a lower risk-adjusted incidence ($20%) than the 33.4% (study definition) and 27.0% (STS definition) we observed. 27 Although the difference from the former is partly explained by the different definitions, the same is not true for the latter. The STS Contemporary Analysis of Perioperative Cardiovascular Surgical Care (CAPS-Care) registry used a definition of postoperative AF much closer to our study definition (''any sustained AF that occurred in the postoperative period while hospitalized'' 28 ) and reported an unadjusted incidence of 28% for 2004 and 2005, 28 which is close to the 29.2% to 30.0% unadjusted incidence we observed for these years.
We found no previous studies in the literature that compared mortality between different definitions of post-CABG AF. To provide some context for judging the magnitude of the effect we observed, however, it is worth noting that the increased risk we observed for patients whose post-CABG AF was versus was not identified in the STS data was similar to that which has been reported for patients with post-CABG AF (defined as the documentation of AF of any duration at any time in the postoperative period on a physician assessment, on the basis of a rhythm strip or 12-lead ECG recording) versus no AF. 3 
Study Strengths and Weaknesses
The study presented provides a unique combination of a large study population ($10,000 patients), limited to patients without a history of AF undergoing a single type of cardiac surgery (isolated CABG), and comprehensive details of the clinical characteristics of all post-CABG AF events detected via continuous in-hospital ECG/telemetry monitoring and documented by a physician in the chart. To our knowledge, it is also the first study to directly assess the impact the choice of definition of AF has on the estimate of incidence of new-onset post-CABG AF, although several previous researchers have noted the inconsistencies between studies as one of the factors contributing to the wide range of incidences reported 14, 15 or on the relationship between post-CABG AF and risk for adverse outcomes. Because we had access only to data regarding in-hospital incidence of post-CABG AF, there may have been additional patients who developed AF after discharge. Such numbers should be small, however, because onset of post-CABG AF is known to peak 2 to 3 days after surgery. 29, 30 Data were collected by abstracting information recorded in medical charts, and we cannot exclude the possibility of abstraction-related errors. Bias related to these errors should be minimal, however, because the abstraction processes were standardized and study personnel were trained for 1 month before starting the first formal abstraction. In the approximately 5% sample of charts we audited, inconsistencies or mistakes in the data collected related to AF-related events were identified in less than 0.5%. Accordingly, in the overall study cohort, misclassification of new-onset post-CABG AF should be less than 0.05%.
Our results show substantial inter-institutional variability in the unadjusted incidence of post-CABG AF. This site variability was accounted for in our analysis but will require further research to determine the extent to which it is caused by differences in patient characteristics (which we also accounted for in our adjusted analysis) versus institutional protocols related to the prevention and management of post-CABG AF.
Meaning of the Study: Implications for Clinicians and Policymakers
Our results show a significantly increased risk of 30-day mortality in patients with post-CABG AF that is missed by the STS definition and data. This is on top of the increased risk even the STS-identified post-CABG AF carries. As such, our results reveal an identifiable at-risk population who should be investigated first and foremost to determine whether their increased risk is being mediated by differences in monitoring and management from those patients whose AF is deemed to require treatment, and is thus identified in the STS data.
In addition to these direct and actionable implications of our study results, there are several indirect implications. Given the strong association between post-CABG AF and poorer survival, 2, 3, [6] [7] [8] [9] the underestimation of incidence that our results demonstrate with reliance on the STS definition could affect the balance of risks and benefits in a patient's treatment options. This will be particularly true if the increased risk we observed for 30-day mortality in patients whose post-CABG AF is being missed by the STS data carries over into increased risk for long-term outcomes. Currently, these patients are being grouped with the ''no AF'' patients, and so may be weakening the ability to observe true differences in risk between patients who do and do not develop post-CABG AF. There are also important implications for research studies investigating the prevention of AF or its impact on outcomes that rely on the STS Adult Cardiac Surgery database (or local/regional databases that apply the same definition). For example, in a study evaluating the effectiveness of a strategy such as perioperative B-blockers or amiodarone [10] [11] [12] to prevent post-CABG AF, if a prophylactic strategy prevents episodes not requiring treatment better than it does those requiring treatment, applying the STS definition will underestimate its effectiveness, and conversely, should the prophylactic strategy have greater effect against AF episodes requiring treatment.
The STS Adult Cardiac Surgery database, which includes data for approximately 95% of the cardiac surgery programs in the United States, 16 provides a valuable resource for many aspects of outcomes research in cardiac surgery. However, its reliance on a definition of postoperative AF dependent on whether treatment of the episode was deemed necessary compromises its utility for evaluations of strategies to prevent AF and for studies examining the impact of postoperative AF on other outcomes. It will also fail to identify approximately 9600 patients undergoing isolated CABG each year who may be at increased risk for the adverse outcomes associated with post-CABG AF and who might therefore benefit from more intensive follow-up after discharge. Therefore, we strongly urge the definition used by expanded to capture all documented events of post-CABG AF, regardless of duration or need for treatment.
CONCLUSIONS
Defining post-CABG AF as episodes requiring treatment significantly underestimates incidence of this complication and misses patients at significantly increased risk for mortality. Further research is needed to determine whether the increased risk for 30-day mortality that we observed in patients whose post-CABG AF was missed by the STS data and definition carries over into long-term outcomes, and whether it is mediated by differences in treatment and management. Such work will form only one part of the broader research needed to effectively identify patients at risk for and prevent development of post-CABG AF in the broader population of patients undergoing CABG, but for those approximately 9600 US patients undergoing isolated CABG each year who develop post-CABG AF missed by the STS definition and who are currently carrying an increased risk of mortality, it could, nonetheless, make a meaningful difference in outcomes.
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